Congenital adrenal hyperplasia - how to improve the transition from adolescence to adult life

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association
B KruseH Mönig

Abstract

Congenital adrenal hyperplasia (CAH) is caused by a defect in the biosynthesis of cortisol that results in maximal activity of the hypothalamic-pituitary adrenal axis with hyperplasia of the adrenals and hyperandrogenism due to the accumulation of androgen precursors. In the salt-wasting subtype of the disorder, which accounts for appr. 75 % of patients with classical CAH, patients are unable to synthesise sufficient amounts of aldosterone and are prone to life-threatening salt-losing crises, whereas the simple virilising form is predominantly characterized by clitoris hypertrophy and posterior labial fusion. In addition, a non-classical variant can be discerned which in most cases is diagnosed at the time of puberty or early adolescence when hirsutism and menstrual irregularities may occur. The vast majority of CAH patients have 21-hydroxylase deficiency (90 - 95 %). Less common forms, such as 11beta-hydroxylase deficiency, will not be discussed in this review. Unfortunately, a considerable number of CAH patients is lost to regular and competent follow-up once they move out of paediatric care. This is most probably the result of insufficient co-operation between paediatric and adult endocrinologists at the time of transition f...Continue Reading

Citations

Jul 16, 2010·International Journal of Pediatric Endocrinology·Selma Feldman Witchel
Sep 9, 2010·The Journal of Clinical Endocrinology and Metabolism·Phyllis W SpeiserUNKNOWN Endocrine Society
Apr 25, 2012·Journal of Pediatric and Adolescent Gynecology·Stephanie E HullmannAmy B Wisniewski
Oct 11, 2011·Pediatric Clinics of North America·Saroj NimkarnMaria I New
May 24, 2011·Journal of Pediatric and Adolescent Gynecology·Selma Feldman Witchel, Ricardo Azziz
Dec 1, 2009·Endocrinology and Metabolism Clinics of North America·Saroj NimkarnMaria I New
Mar 16, 2017·Korean journal of pediatrics·Jin-Ho Choi, Han-Wook Yoo
Dec 1, 2007·Electrolyte & Blood Pressure : E & BP·Jun Hyuk SongByoung Soo Cho
Nov 16, 2005·Hormone Research·Heiner Mönig, Wolfgang Sippell
Jan 1, 2009·Expert Review of Endocrinology & Metabolism·Karen Lin-SuMaria I New
Mar 13, 2014·The Journal of Clinical Endocrinology and Metabolism·Anuja Dokras, Selma Feldman Witchel
Jun 28, 2019·Frontiers in Endocrinology·Sarantis Livadas, Christina Bothou
Oct 3, 2018·The Journal of Clinical Endocrinology and Metabolism·Phyllis W SpeiserPerrin C White
Nov 26, 2019·Journal of Pediatric and Adolescent Gynecology·Christine OsborneSarah K McQuillan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.